FLT1 and neoplasm: VEGF-induced phosphorylation of VEGFR-1, -2 and -3 in vitro is specifically blocked by PTK787, which leads to inhibition of endothelial cell proliferation, differentiation, tumor cell migration and VEGF- and platelet-derived growth factor (PDGF)-induced angiogenesis (6,20–25).